Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/1996
05/29/1996CN1123185A Immune couplet
05/29/1996CN1031893C A mutant of protein for basic fibroblast growth factor, DNA and use thereof
05/28/1996US5521319 Biotinylation reagent and method of use thereof
05/28/1996US5521297 Nucleic acids encoding human metabotropic glutamate receptors
05/28/1996US5521291 Adenovirus conjugates for gene therapy
05/28/1996US5521288 CD28IG fusion protein
05/28/1996US5521285 CTAA 28A32, the antigen recognized by MCA 28A32
05/28/1996US5521085 Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
05/28/1996US5521067 Bone marrow cell adhesion molecules and process for detecting adherence between cell adhesion molecules and cells generally
05/28/1996US5520914 Antibodies to angiogenin: immunotherapeutic agents
05/28/1996CA2078996C A bifunctional dtpa-type ligand
05/28/1996CA1338365C Synthetic antigens of sialic acid and derivatives thereof
05/23/1996WO1996015452A1 METHODS FOR AIDING IN THE DIAGNOSIS OF ALZHEIMER'S DISEASE BY MEASURING AMYLOID-β PEPTIDE (X- ≥41) AND TAU
05/23/1996WO1996015273A1 Method for identifying protective antigens for eliciting neutralizing antibodies
05/23/1996WO1996015272A1 Neural thread protein gene expression and detection of alzheimer's disease
05/23/1996WO1996015249A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996WO1996015248A1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
05/23/1996WO1996015244A2 Sensory and motor neuron derived factor (smdf)
05/23/1996WO1996015229A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
05/23/1996WO1996015227A1 Methods of inducing cell death of primitive hematopoietic cells and compositions for induction thereof
05/23/1996WO1996015153A1 Human antibodies to t-cell receptor peptides and methods for their preparation
05/23/1996WO1996015152A1 Antiannexin-v monoclonal antibody, process for producing the same, and use therof
05/23/1996WO1996015147A1 Human stanniocalcin-alpha
05/23/1996WO1996015144A2 Chromosome 21 gene marker, compositions and methods using same
05/23/1996WO1996014877A1 Novel tumor suppressor gene, hic-1
05/23/1996WO1996014867A1 Dna encoding canine immunoglobulins
05/23/1996WO1996014865A1 Methods for inhibiting graft versus host disease in bone marrow transplantation
05/23/1996WO1996014864A1 Immunoliposomes that optimize internalization into target cells
05/23/1996WO1996014860A1 Process for identifying para cation channel modulators
05/23/1996WO1996010580A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
05/23/1996WO1996009066A3 Method of treatment of human immunodeficiency virus (hiv) infection
05/23/1996CA2205414A1 Novel tumor suppressor gene, hic-1
05/23/1996CA2205138A1 Human antibodies to t-cell receptor peptides and methods for their preparation
05/23/1996CA2204914A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996CA2204863A1 Method for identifying protective antigens for eliciting neutralizing antibodies
05/23/1996CA2204849A1 Process for identifying para cation channel modulators
05/23/1996CA2204379A1 Sensory and motor neuron derived factor (smdf)
05/23/1996CA2203654A1 Human stanniocalcin-alpha
05/23/1996CA2203525A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
05/22/1996EP0712931A2 Interferon-gamma production inducing polypeptide, monoclonal antibody, and agent for interferon-gamma susceptive disease
05/22/1996EP0712926A2 Fish pancreatic disease virus
05/22/1996EP0712863A1 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use
05/22/1996EP0712632A1 Remedy for diseases characterized by abnormal accumulation or activation of leukocyte
05/22/1996EP0712497A1 Reagents and methods for the detection and quantification of testosterone in fluid samples
05/22/1996EP0712414A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences
05/22/1996EP0712313A1 Pro-cytotoxic drug conjugates for anticancer therapy
05/22/1996EP0712312A1 Suppression of inhibitors
05/22/1996EP0712307A1 Methods for b-cell population control
05/22/1996EP0712277A1 Jak kinases and regulation of cytokine signal transduction
05/22/1996EP0486526B1 Tumour necrosis factor binding ligands
05/21/1996US5519120 Urokinase-type plasminogen activator receptor antibodies
05/21/1996US5519118 Human MDM2 protein involved in human tumors
05/21/1996US5519114 Retroviral superantigens, superantigen peptides, and methods of use
05/21/1996US5519001 CETP inhibitor polypeptide antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
05/21/1996US5518916 Cloned Babesia DNA
05/21/1996US5518899 Propagation with polypeptides and carbohydrates for treatment of viricides
05/21/1996US5518889 Immunoassay methods using single polypeptide chain binding molecules
05/21/1996US5518724 Infectious bursal disease virus
05/21/1996US5518723 Vaccines containing antibodies and epitopes
05/21/1996US5518721 Anticaries agents
05/21/1996US5518720 Monoclonal antibody
05/17/1996WO1996014580A1 Assay for marker of human polymorphonuclear leukocyte elastase activity
05/17/1996WO1996014412A2 cDNA ENCODING A BMP TYPE II RECEPTOR
05/17/1996WO1996014411A1 Methods for the diagnosis of glaucoma
05/17/1996WO1996014401A1 Transgenic organisms and their uses
05/17/1996WO1996014399A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996WO1996014398A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014397A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014394A1 Human dna ligase iii
05/17/1996WO1996014341A1 Monoclonal antibody capable of binding to pna/nucleic acid complexes
05/17/1996WO1996014340A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014338A1 ELIMINATION OF RHEUMATOID FACTOR INTERFERENCE USING ANTI-Fd ANTIBODIES
05/17/1996WO1996014337A1 Interference-suppressing reagent specific to certain classes of antibodies
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014111A1 Golf club receptacle
05/17/1996WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
05/17/1996CA2320579A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996CA2204491A1 Modified neuropeptide y receptors
05/17/1996CA2204429A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996CA2204428A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2204427A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2204397A1 Interference-suppressing reagent specific to certain classes of antibodies
05/17/1996CA2204380A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996CA2203935A1 Transgenic organisms and their uses
05/17/1996CA2203651A1 Dna ligase iv
05/15/1996EP0711831A2 Rabbit G protein coupled receptor
05/15/1996EP0711565A1 Inhibiting growth of leukemic cells by targeting HER-2 protein
05/15/1996EP0711563A1 Novel Borrelia vaccine
05/15/1996EP0711415A1 Immunoassay for detecting collagen or collagen fragments
05/15/1996EP0711345A1 B7-2: ctl a4/cd 28 counter receptor
05/15/1996EP0711310A1 Human antibodies against varicella-zoster virus
05/15/1996EP0711305A1 Protegrins
05/15/1996EP0711176A1 Stabilised immunoglobulin preparations and method for preparing same
05/15/1996EP0537168B1 Ctaa 28a32, the antigen recognized by mca 28a32
05/15/1996EP0462182B1 Matrix metalloproteinase peptides: role in diagnosis and therapy
05/15/1996EP0438474B1 Production of antibodies from transgenic animals
05/15/1996DE4441408A1 DNA-Sequenzen aus Solanum tuberosum kodierend Enzyme, die an der Stärkesynthese beteiligt sind, Plasmide, Bakterien, Pflanzenzellen und transgene Pflanzen enhaltend diese Sequenzen DNA sequences from Solanum tuberosum coding for enzymes involved in starch synthesis, plasmids, bacteria, plant cells and transgenic plants, these sequences enhaltend
05/15/1996CN1122613A Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
1 ... 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 ... 1494